Publications

This report summarizes our monitoring of the inquiries and investigations the California Department of Corrections and Rehabilitation performed from January 1, 2021, through December 31, 2021 into allegations of staff misconduct incarcerated persons raised through the department’s grievance and appeal processes. The report concludes that despite its revised regulatory framework for processing its staff misconduct cases, the California Department of Corrections and Rehabilitation continues to earn poor ratings; flawed practices by departmental staff into staff misconduct allegations cause inquiries and investigations to be deficient.

This report contains our assessment of the medical care provided to incarcerated persons at California Institution for Men between October 2021 and March 2022. We rated the overall quality of health care provided at California Institution for Men during this time period as adequate.

This report contains our assessment of the medical care provided to incarcerated persons at Sierra Conservation Center between August 2021 and January 2022. We rated the overall quality of health care provided at Sierra Conservation Center during this time period as adequate.

This annual report summarizes the work the Office of the Inspector General completed during 2022, including the 18 public reports we issued. The report also details the work the OIG performs that was not highlighted in other reports issued during the year.

This report contains our assessment of the medical care provided to incarcerated persons at Chuckawalla Valley State Prison between July 2021 and December 2021. We rated the overall quality of health care provided at Chuckawalla Valley State Prison during this time period as adequate.

See the accompanying Fact Sheet. In this audit, we set out to determine whether the department’s drug interdiction processes provide effective means of preventing drugs from entering prison grounds, detecting and discovering drugs within prisons, and investigating the sources of discovered drugs. We also evaluated the department’s process for collecting and reporting data related to drug discoveries and performed transactional testing to assess reliability of the data. Finally, we reviewed the data to assess the impact of operational restrictions implemented in response to the novel coronavirus (COVID-19) pandemic, on the introduction of drugs in prisons. In the report, we provide the department with 19 recommendations to improve its drug interdiction processes.

This report contains our assessment of the medical care provided to incarcerated persons at Mule Creek State Prison between June 2021 and November 2021. We rated the overall quality of health care provided at Mule Creek State Prison during this time period as adequate.

This report contains our assessment of the medical care provided to incarcerated persons at Pleasant Valley State Prison between May 2021 and October 2021. We rated the overall quality of health care provided at Pleasant Valley State Prison during this time period as adequate.

This report contains our assessment of the medical care provided to incarcerated persons at California State Prison, Sacramento between May 2021 and October 2021. We rated the overall quality of health care provided at California State Prison, Sacramento during this time period as inadequate.